Has Michelle Davis received payments from drug or device companies?

Yes. Drug and device makers reported $5,926 in general payments to Michelle Davis across 213 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Michelle Davis did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Michelle Davis come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Michelle Davis

Family Medicine · la Jolla, CANPI 1598404261

Payments from drug & device makers

$5,926in general payments, 2019–2025

Across 213 payments — averaging $27.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AstraZeneca$649
Pfizer$526
Novartis$478
Johnson & Johnson$379
Sobi, Inc$298
Takeda Pharmaceuticals U.S.A., Inc.$235
plus $3K from 37 others

What the payments were for

Food & beverage$5,52093%
Education$4067%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AstraZeneca(2 entities)	21	$649
Pfizer	20	$526
Novartis	19	$478
Johnson & Johnson	16	$379
Sobi, Inc	8	$298
Takeda Pharmaceuticals U.S.A., Inc.	5	$235
Karyopharm Therapeutics Inc.	4	$210
Bristol Myers Squibb	8	$199
Seagen Inc.	7	$189
Beigene USA, Inc.	8	$188
Regeneron Healthcare Solutions, Inc.	6	$185
Incyte Corporation	7	$181
Bayer	7	$167
Lilly USA, LLC	4	$158
Puma Biotechnology, Inc.	6	$149
AbbVie	7	$141
GSK	6	$134
Beone Medicines USA, Inc.	1	$127
Daiichi Sankyo Inc.	6	$121
Taiho Oncology, Inc.	4	$109
Eisai Inc.	4	$103
Octapharma USA, Inc.	4	$102
Recordati_rare_diseases_inc.	3	$96
Tersera Therapeutics LLC	3	$79
Ipsen Biopharmaceuticals, Inc	3	$76
Array Biopharma Inc	3	$76
Pharmaessentia USA Corporation	2	$64
Mirati Therapeutics, Inc.	2	$48
Morphosys, US Inc.	2	$46
Myriad Genetic Laboratories, Inc.	2	$45
Foundation Medicine, Inc.	2	$43
Agios Pharmaceuticals, Inc.	2	$41
Merck	1	$33
Pharmacyclics LLC, An Abbvie Company	1	$30
Gilead	1	$30
Legend Biotech USA Inc.	1	$29
Verity Pharmaceuticals Inc.	1	$26
Deciphera Pharmaceuticals Inc.	1	$25
Dendreon Pharmaceuticals LLC	1	$25
EUSA Pharma (US) LLC	1	$23
Spectrum Pharmaceuticals Inc.	1	$22
Genmab U.S., Inc.	1	$21
E.r. Squibb & Sons, L.L.C.	1	$20

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

TEVIMBRA$127
Enhertu$125
XPOVIO$117
RETEVMO$106
JAYPIRCA$106

How this compares

$5,926 in reported general payments places this provider in the 90th percentile of 10,533 family medicine providers in California.

See all family medicine providers in California →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
KineretAnakinra	12	$66,887
Escitalopram Oxalate	11	$184
Potassium Chloride	16	$136
Zolpidem Tartrate	12	$96
Levothyroxine Sodium	11	$44

Paid to pharmacies, not to this prescriber.

Other family medicine in la Jolla

Amina HaggagNorthridge$112.8M
Steven ReynoldsLong Beach$53M
Rizwana MohseniLake Forest$26.7M
Daniel JohnsonSan Diego$15.7M
Stacey LayleSan Diego$14.8M
Apinya VutikullirdCypress$14.3M
Hanid AudishSpring Valley$13.6M
Augusto FocilOxnard$12.6M
Jack VuLong Beach$10.1M
Suzanne FussellOxnard$8.9M

See the full list for California →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →